Teva's UK Appeal Over Patent For MS Drug Gilenya Falls Flat
An appeals court rejected Teva's bid to revive its suit seeking to get Novartis' blockbuster multiple sclerosis drug Gilenya declared obvious, concluding Thursday that any benefits the declaration would have on...To view the full article, register now.
Already a subscriber? Click here to view full article